SOLV
Q4 2026 EPS Estimate
$1.40
Nov 5, 2026 · Reports after close
Revenue Estimate
$1.93B
FY2026E EPS$7.04
FY2027E EPS$7.27

Analyst Sentiment

Wall St. Consensus
Buy
11 analysts·Moderate coverage
66
Score
8 Buy (73%)2 Hold (18%)1 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
873%
Hold
218%
Sell
19%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$43.00
-49.8%
Consensus
$95.00
+11.0%
Bull
$113.00
+32.0%
12-Month Target Range11 analysts
$43.00$95.00$113.00
Current $85.58Consensus
Current Price
$85.58
Upside to Consensus
$9.42

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.49%
EPS+3.28%
FY2028
Rev+3.90%
EPS+9.81%
FY2029
Rev+4.00%
EPS+7.45%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$8.22B$8.51B$8.84B$9.19B$9.56B
Low$8.10B$8.40B$8.70B$9.08B$9.44B
High$8.40B$8.71B$9.00B$9.31B$9.69B
EBITDA Avg$2.21B$2.29B$2.38B$2.47B$2.57B
Low$2.18B$2.26B$2.34B$2.44B$2.54B
High$2.26B$2.34B$2.42B$2.51B$2.61B
EBIT Avg$1.66B$1.71B$1.78B$1.85B$1.93B
Low$1.63B$1.69B$1.75B$1.83B$1.90B
High$1.69B$1.75B$1.81B$1.88B$1.95B
Net Income Avg$1.23B$1.24B$1.36B$1.50B$1.87B
Low$1.23B$1.23B$635M$1.48B$1.84B
High$1.24B$1.31B$1.90B$1.53B$1.90B
EPS Avg$7.04$7.27$7.98$8.58$10.68
Low$7.01$7.00$3.62$8.44$10.50
High$7.06$7.49$10.84$8.72$10.86
Analysts (Rev / EPS)10 / 1010 / 1011 / 65 / 35 / 2
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$1.94B$2.08B$2.08B$2.26B$2.03B$2.15B$2.17B$2.40B
Low$1.89B$2.06B$2.05B$2.23B$2.00B$2.12B$2.14B$2.37B
High$2.04B$2.09B$2.12B$2.31B$2.07B$2.19B$2.21B$2.45B
EBITDA Avg$522M$559M$560M$609M$545M$578M$583M$646M
Low$509M$554M$552M$600M$538M$570M$575M$637M
High$548M$562M$571M$621M$557M$590M$595M$659M
EBIT Avg$390M$418M$419M$455M$408M$432M$437M$483M
Low$381M$414M$413M$449M$402M$426M$430M$476M
High$410M$420M$428M$465M$417M$441M$446M$493M
Net Income Avg$240M$307M$286M$349M$300M$336M$314M$412M
Low$225M$294M$280M$343M$294M$329M$308M$404M
High$255M$320M$293M$359M$308M$345M$323M$423M
EPS Avg$1.38$1.76$1.64$2.00$1.72$1.93$1.80$2.36
Low$1.29$1.69$1.61$1.97$1.69$1.89$1.77$2.32
High$1.46$1.84$1.68$2.06$1.77$1.98$1.85$2.43
Analysts (Rev / EPS)7 / 84 / 42 / 12 / 12 / 12 / 11 / 21 / 2

Earnings Surprises

Recent Analyst Actions

Aug 6, 2026Stifel Nicolaus
Solventum price target raised to $100 from $90 at Stifel
Target:$100.00
+17.9%from $84.82
Aug 6, 2026UBS
Solventum price target raised to $101 from $95 at UBS
Target:$101.00
+15.5%from $87.47
Aug 6, 2026Mizuho Securities
Solventum price target raised to $113 from $100 at Mizuho
Target:$113.00
+29.2%from $87.47
Aug 6, 2026KeyBanc
Solventum price target raised to $102 from $93 at KeyBanc
Target:$102.00
+16.6%from $87.47
Aug 6, 2026BTIG
Solventum price target raised to $95 from $91 at BTIG
Target:$95.00
+8.6%from $87.47
Jul 28, 2026UBS
Solventum assumed with Buy from Neutral at UBS
Target:$95.00
+18.1%from $80.47
Jul 13, 2026BTIG
Solventum price target raised to $91 from $89 at BTIG
Target:$91.00
+18.6%from $76.70
Jul 8, 2026BMO Capital
BMO Capital starts Solventum at Market Perform amid 'many execution hurdles'
Target:$81.00
+7.7%from $75.18
Jun 1, 2026Jefferies
SOLV Energy Inc (MWH) PT Raised to $43 at JefferiesMember Login
Target:$43.00
-42.6%from $74.95
May 15, 2026Wedbush
Solventum initiated with an Outperform at Wedbush
Target:$94.00
+26.3%from $74.42
May 6, 2026UBS
Solventum price target lowered to $78 from $82 at UBS
Target:$78.00
+9.3%from $71.36
May 6, 2026Stifel Nicolaus
Solventum price target lowered to $90 from $105 at Stifel
Target:$90.00
+30.4%from $69.04
May 6, 2026KeyBanc
Solventum price target raised to $93 from $92 at KeyBanc
Target:$93.00
+34.7%from $69.04
Apr 27, 2026KeyBanc
Solventum price target lowered to $92 from $99 at KeyBanc
Target:$92.00
+34.3%from $68.52
Apr 17, 2026Piper Sandler
Solventum price target lowered to $92 from $98 at Piper Sandler
Target:$92.00
+33.6%from $68.88
Jan 26, 2026KeyBanc
Solventum upgraded to Overweight from Sector Weight at KeyBanc
Target:$97.00
+22.9%from $78.91
Jan 20, 2026Mizuho Securities
Solventum upgraded to Outperform from Neutral at Mizuho
Target:$100.00
+25.8%from $79.48
Jan 7, 2026Stifel Nicolaus
Solventum price target raised to $105 from $88 at Stifel
Target:$105.00
+26.3%from $83.16
Dec 2, 2025BTIG
BTIG upgrades Solventum to Buy on better setup in 2026
Target:$100.00
+16.9%from $85.56
Oct 1, 2025UBS
Solventum initiated with a Neutral at UBS
Target:$77.00
+5.5%from $73.00
Jul 15, 2025Morgan Stanley
Solventum upgraded to Overweight from Equal Weight at Morgan Stanley
Target:$103.00
+39.8%from $73.68
Mar 3, 2025Mizuho Securities
Solventum price target raised to $82 from $70 at Mizuho
Target:$82.00
+2.3%from $80.16
Feb 28, 2025Wells Fargo
Solventum price target raised to $75 from $73 at Wells Fargo
Target:$75.00
-6.0%from $79.75
Dec 3, 2024Mizuho Securities
Solventum initiated with a Neutral at Mizuho
Target:$70.00
-3.1%from $72.28
Oct 7, 2024Stifel Nicolaus
Solventum initiated with a Buy at Stifel
Target:$82.00
+23.7%from $66.29
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.